SCHEMBL7015142

SCHEMBL7015142

Brc1ccnc(Nc2ccccc2)n1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 10/20 0.65
CDK2 P24941 3/20 0.65
CDK1 P06493 3/20 0.65
PRKCD Q05655 2/20 0.65
PDPK1 O15530 2/20 0.65
LYN P07948 2/20 0.65
FGFR1 P11362 2/20 0.65
FGFR3 P22607 2/20 0.65
RPS6KB1 P23443 2/20 0.65
MARK3 P27448 2/20 0.65
BLK P51451 2/20 0.65
RPS6KA3 P51812 2/20 0.65
ERBB4 Q15303 2/20 0.65
MARK2 Q7KZI7 2/20 0.65
PLK3 Q9H4B4 2/20 0.65
CHEK1 O14757 1/20 0.65
IKBKB O14920 1/20 0.65
NPC1 O15118 1/20 0.65
CHEK2 O96017 1/20 0.65
PRKCG P05129 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL440486 0.78 AURKA (1.00) AURKACDK2CDK1PRKCDPDPK1
SCHEMBL4624975 0.77 NPC1 (0.65) AURKACDK2CDK1PRKCDPDPK1
SCHEMBL18594621 0.77 SCN9A (0.67) AURKACDK2CDK1PRKCDPDPK1
SCHEMBL3575061 0.77 AURKA (0.65) AURKACDK2CDK1PRKCDPDPK1
SCHEMBL857880 0.77 AURKA (0.70) AURKACDK2CDK1PRKCDPDPK1
SCHEMBL911 0.77 AURKA (0.63) AURKACDK2CDK1PRKCDPDPK1
SCHEMBL15968669 0.77 AURKA (0.63) AURKACDK2CDK1PRKCDPDPK1
SCHEMBL2280151 0.77 AURKA (0.59) AURKACDK2CDK1PRKCDPDPK1
SCHEMBL30847372 0.76 AURKA (0.72) AURKAMAPTMAPK1KDRMAPK8
SCHEMBL27110454 0.76 AURKA (0.72) AURKAMAPTMAPK1KDRMAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024044757-A1 AMINOPYRIMIDINE AND AMINOTRIAZINE DERIVATIVES AS MYC PROTEIN MODULATORS Sanford Burnham Prebys Medical Discovery Institute (US) 2024-02-29 WO disclosed
WO-2024044757-A1 AMINOPYRIMIDINE AND AMINOTRIAZINE DERIVATIVES AS MYC PROTEIN MODULATORS Sanford Burnham Prebys Medical Discovery Institute (US) 2024-02-29 WO disclosed
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 EP disclosed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 US disclosed
EP-1206265-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-08-07 EP disclosed
EP-1206265-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 EP disclosed
WO-2001000213-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed